Annales françaises d'anesthèsie et de rèanimation
-
Ann Fr Anesth Reanim · Jan 1983
Comparative Study[Determination of the dose-effect curve of vecuronium in anesthetized man].
Dose-response curves have been determined in 37 healthy subjects, after injection of a single bolus of Organon NC 45 (vecuronium or Norcuron). The doses used were 0.0125, 0.025, 0.037 and 0.05 mg X kg-1. The ulnar nerve was stimulated at the wrist and the force of thumb adduction measured. ⋯ The effective doses (ED) were: ED50 at 0.024 mg X kg-1, ED90 at 0.034 mg X kg-1 and ED95 at 0.037 mg X kg-1. At 0.05 mg X kg-1, the degree of twitch inhibition was 99.2 +/- 0.6%, the delay of maximum effect was 7.7 +/- 1.4 min, and the length of action (up to 90% recovery) was 27.2 +/- 2.3 min. Vecuronium is therefore a potent neuromuscular blocking agent with a relatively short duration of action.
-
The cardiovascular effects of vecuronium (Organon NC 45 or Norcuron) in man were determined through different protocols using continuous recording of heart rate, arterial blood pressure and parameters obtained by a Swan-Ganz catheter. In healthy anaesthetized patients (n = 23), the effects of a dose of 0.1 mg X kg-1 pancuronium (group A) were compared to those of two doses of vecuronium: 0.1 mg X kg-1 (group B) and 0.3 mg X kg-1 (group C). Pancuronium induced an increase in heart rate (+12%), arterial pressure (+16%) and cardiac index (+8%). ⋯ The doses were approximately equipotent in groups A, B and C, whereas the dose of 0.3 mg X kg-1 in group G is about 10 times the 90% effective dose of vecuronium. In geriatric patients with per- or postoperative circulatory deficiency (group H; n = 10, mean age 83 yr), no hemodynamic side effects were observed. Vecuronium seems to be a non-depolarizing neuromuscular blocking agent devoid of cardiovascular side-effects at the generally usual doses.
-
Ann Fr Anesth Reanim · Jan 1983
Comparative Study[Comparative study of ORG NC 45 and pancuronium during anesthesia].
The muscle relaxant effects of ORG NC 45 and pancuronium were compared in anesthetized patients with normal liver and renal functions. In all patients, the muscle relaxant effect was monitored by measuring the strength of the adductor pollicis muscle elicited by supramaximal stimulation of the ulnar nerve at the wrist. Different modes of administration of the muscle relaxants were used. ⋯ The dose of 100 micrograms X kg-1 produced adequate conditions for tracheal intubation 3 to 4 min after the administration of the muscle relaxant. The recovery of the muscle strength to 75% of control value was achieved 46 min and 100 min after a single dose of 100 micrograms X kg-1 of ORG NC 45 and pancuronium respectively. The interval of time between repeat injections averaged 20 min for ORG NC 45 and 40 min for pancuronium.
-
Ann Fr Anesth Reanim · Jan 1983
[Surgical ligation of patent ductus arteriosus in the very-low-birth-weight premature infant].
Three recent cases of surgical closure of ductus arteriosus in very low birth weight infants (less than 1 000 g) are reported. The indications of both surgical and pharmacological closure in very low birth weight premature infants are discussed. The necessity of an early closure of a patent ductus arteriosus is now admitted in the very premature infant, but the use of indomethacin in the first days of life is often impossible because of its side-effects. The use of adapted non-invasive monitoring devices during surgery allows a better control of anaesthesia.